LUCID DIAGNOSTICS INC.

(LUCD)
  Rapport
Geschatte realtime Cboe BZX  -  19/05 17:45:05 CEST
2.200 USD   +0.92%
12/05LUCID DIAGNOSTICS INC. : Needham & Co. herhaalt koopadvies
MM
11/05Winstflits (LUCD) LUCID DIAGNOSTICS meldt Q1 Inkomsten $189.000
MT
11/05Lucid Diagnostics Inc. Rapporteert Winstresultaten voor het Eerste Kwartaal Geëindigd op 31 Maart, 2022
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op LUCID DIAGNOSTICS INC.
16/05LUCID DIAGNOSTICS INC. Management's Discussion and Analysis of Financial Condition and..
12/05LUCID DIAGNOSTICS INC. : Results of Operations and Financial Condition, Regulation FD Disc..
11/05TRANSCRIPT : Lucid Diagnostics Inc., Q1 2022 Earnings Call, May 11, 2022
11/05Earnings Flash (LUCD) LUCID DIAGNOSTICS Reports Q1 Revenue $189,000
11/05Lucid Diagnostics Provides Business Update and Preliminary First Quarter 2022 Financial..
11/05Lucid Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2..
09/05LUCID DIAGNOSTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
09/05Lucid Diagnostics' Laboratory Executes Participating Provider Agreement with MediNcreas..
25/04Lucid Diagnostics to Hold a Business Update Conference Call on May 11, 2022
12/04Certain Stock Options of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Endi..
12/04Certain Common Stock of Lucid Diagnostics Inc. are subject to a Lock-Up Agreement Endin..
06/04LUCID DIAGNOSTICS : Annual Report (Form 10-K)
06/04LUCID DIAGNOSTICS INC. Management's Discussion and Analysis of Financial Condition and..
05/04LUCID DIAGNOSTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
04/04Lucid Diagnostics Provides Updates on Newly Published Esophageal Precancer Clinical Gui..
01/04LUCID DIAGNOSTICS INC. : Entry into a Material Definitive Agreement, Unregistered Sale of ..
30/03Lucid Diagnostics to Participate in the Needham 21st Annual Healthcare Conference
30/03LUCID DIAGNOSTICS : PAVmed Provides Business Update and Preliminary Fourth Quarter and Ful..
29/03LUCID DIAGNOSTICS INC. Results of Operations and Financial Condition, Regulation FD Di..
28/03LUCID DIAGNOSTICS : Provides Business Update and Preliminary Fourth Quarter and Full Year ..
28/03Lucid Diagnostics Q4 Loss Wider vs. Year Ago
28/03LUCID DIAGNOSTICS INC. : Results of Operations and Financial Condition, Regulation FD Disc..
28/03Lucid Diagnostics Inc. Reports Earnings Results for the Fourth Quarter Ended December 3..
28/03Lucid Diagnostics Inc. Reports Earnings Results for the Full Year Ended December 31, 20..
28/03Earnings Flash (LUCD) LUCID DIAGNOSTICS Posts Q4 Revenue $0.3M
28/03Earnings Flash (LUCD) LUCID DIAGNOSTICS Posts Q4 Loss $-0.22
28/03Lucid Diagnostics Provides Business Update and Preliminary Fourth Quarter and Full Year..
24/03PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuardģ Study
23/03LUCID DIAGNOSTICS INC. : Change in Directors or Principal Officers, Financial Statements a..
23/03Lucid Diagnostics Inc. Appoints Shaun 'Neil as Chief Operating Officer and Executive Vi..
23/03PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers
23/03Lucid Diagnostics Opens Test Centers in Three Cities to Detect Esophageal Pre-Cancer
23/03Lucid Diagnostics Inc. Launches Lucid Test Centers in three new metropolitan areas-Seat..
08/03PAVmed to Hold a Business Update Conference Call on March 29, 2022
07/03LUCID DIAGNOSTICS : to Hold a Business Update Conference Call on March 28, 2022 - Form 8-K
07/03LUCID DIAGNOSTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
03/03LUCID DIAGNOSTICS : PAVmed Subsidiary Lucid Diagnostics Launches LucidDx Labs to Accommoda..
03/03LUCID DIAGNOSTICS INC. : Completion of Acquisition or Disposition of Assets, Unregistered ..
24/02PAVmed Names Shaun O'Neil Chief Operating Officer
24/02PAVmed Appoints Shaun O'Neil as Chief Operating Officer
15/02Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed..
20/01LUCID DIAGNOSTICS INC. : Change in Directors or Principal Officers, Financial Statements a..
12/01PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team
07/01LUCID DIAGNOSTICS : to Participate in a Fireside Chat at the 24th Annual Needham Virtual G..
07/01LUCID DIAGNOSTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
2021LUCID DIAGNOSTICS INC.(NASDAQGM : LUCD) added to S&P TMI Index
2021LUCID DIAGNOSTICS : PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Pro..
2021LUCID DIAGNOSTICS INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
2021Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHe..
2021LUCID DIAGNOSTICS INC. Management's Discussion and Analysis of Financial Condition and..
2021PAVmed's Q3 Adjusted Loss Widens
2021PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial R..
2021LUCID DIAGNOSTICS INC. : Regulation FD Disclosure (form 8-K)
2021Lucid Diagnostics Launches Next Phase of Lucid Test Centers
2021PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021
2021LUCID DIAGNOSTICS INC. : Regulation FD Disclosure (form 8-K)
2021Lucid Diagnostics Inc. Appoints Suman Verma as Chief Scientific Officer
2021LUCID DIAGNOSTICS : Closes $70 Million IPO
2021LUCID DIAGNOSTICS : Announces Closing of Nasdaq Initial Public Offering
2021LUCID DIAGNOSTICS INC. : Other Events (form 8-K)
2021LUCID DIAGNOSTICS INC.(NASDAQGM : LUCD) added to NASDAQ Composite Index
2021Health Care Stocks Moderate Slightly in Afternoon Trading
2021SECTOR UPDATE : Health Care
2021Top Midday Decliners
2021LUCID DIAGNOSTICS : Shares Drop in Nasdaq Trading Debut
2021LUCID DIAGNOSTICS : Prices IPO at $14 Per Share
2021Lucid Diagnostics Inc. has completed an IPO in the amount of $70 million.
2021Lucid Diagnostics Inc. has filed an IPO in the amount of $57.5 million.